Expertise in
34
conditions

Dr. Jay B. Nayak

Oncology
Anderson Area Cancer Center
2000 E Greenville St Ste 5000, 
Anderson, SC 
Accepting New Patients
Expertise in
34
conditions
Anderson Area Cancer Center
2000 E Greenville St Ste 5000, 
Anderson, SC 

Overview

Jay Nayak is an Oncologist practicing medicine in Anderson, South Carolina.

Dr. Nayak is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Lung Cancer, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 6 clinical trials. Dr. Nayak is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MI

Hospital Affiliations

Anmed Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Anderson Area Cancer Center
2000 E Greenville St Ste 5000, Anderson, SC 29621

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase II Study of Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
Randomized Phase II Study of Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug, Other
Study Drugs: Capecitabine, Carboplatin, Cisplatin, Etoposide, Temozolomide
Study Phase: Phase 2
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Behavioral
Study Phase: Phase 3
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Drug, Other
Study Drugs: Capecitabine, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

3 Total Publications

Canadian Urological Association guideline: Management of small renal masses - Full-text.
Canadian Urological Association guideline: Management of small renal masses - Full-text.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: February 08, 2022
Similar Doctors
Expertise in
75
conditions
Expertise in
75
conditions
Referral may be required

Anderson Oncology-Hematology Clinic PA

2000 E Greenville St Ste 5000, 
Anderson, SC 
 (0.1 miles away)
864-224-5765
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Doster is an Oncologist practicing medicine in Anderson, South Carolina. Dr. Doster is highly rated in 75 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Lynch Syndrome, Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Doster is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required
Before you request

Prisma Health Cancer Institute – Faris Rd.

900 West Faris Road, 
Greenville, SC 
 (24.2 miles away)
864-679-3900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Larry Puls is an Oncologist practicing medicine in Greenville, South Carolina. Dr. Puls is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Hernia Surgery, and Salpingo-Oophorectomy. Dr. Puls is board certified in American Board Of Obstetrics And Gynecology. Dr. Puls is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

Gynecologic Oncology (Spartanburg)

101 East Wood Street, Floor 3, 
Spartanburg, SC 
 (49.4 miles away)
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carlton Schwab is an Oncologist practicing medicine in Spartanburg, South Carolina. He has been practicing medicine for over 17 years. Dr. Schwab is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Ovarian Carcinosarcoma, Endometrial Cancer, Ovarian Cancer, Bladder Reconstruction, and Hernia Surgery. Dr. Schwab is board certified in American Board Of Obstetrics & Gynecology, (Obstetrics & Gynecology), and (Obstetrics & Gynecology, Gynecologic Oncology). Dr. Schwab is currently accepting new patients.

Frequently Asked Questions about Dr. Jay B. Nayak

How do I make an appointment with Dr. Jay B. Nayak?

You can book an appointment with Dr. Jay B. Nayak by calling their office at 864-512-1658. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jay B. Nayak a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jay B. Nayak is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jay B. Nayak specialize in?

While Dr. Jay B. Nayak is a Oncology, they have specific expertise in Colorectal Cancer, Lung Cancer, and Familial Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Jay B. Nayak participate in research or clinical trials?

Yes. Dr. Jay B. Nayak has published 3 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Dr. Jay B. Nayak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jay B. Nayak accept my insurance?

Dr. Jay B. Nayak accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 864-512-1658 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nayak's expertise for a condition
ConditionClose
    View All 16 Distinguished Conditions
    View All 18 Advanced Conditions
    View All 106 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile